P. Whiteaker et al., I-125-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain, MOLEC PHARM, 57(5), 2000, pp. 913-925
alpha-Conotoxin MII (CtxMII), a peptide toxin from the venom of the predato
ry cone snail Conus magus, displays an unusual nicotinic pharmacology. Spec
ific binding of a radioiodinated derivative (I-125-alpha-CtxMII) was identi
fied in brain region homogenates and tissue sections. Quantitative autoradi
ography indicated that I-125-alpha-CtxMII binding sites have an unique phar
macological profile and distribution in mouse brain, being largely confined
to the superficial layers of the superior colliculus, nigrostriatal pathwa
y, optic tract, olivary pretectal, and mediolateral and dorsolateral genicu
late nuclei. Expression of alpha-CtxMII binding sites in the nigrostriatal
pathway, combined with evidence for alpha-CtxMII-sensitivity of nicotine-in
duced [H-3]dopamine release in rodent striatal preparations indicates that
I-125-alpha-CtxMII binding nicotinic acetylcholine receptors are likely to
be physiologically important. Unlabeled alpha-CtxMII potently (K-i < 3 nM)
competed for a subset of [H-3]epibatidine binding sites in mouse brain homo
genates, but weakly (IC50 > 10 mu M) interacted with I-125-alpha-bungarotox
in and (-)-[H-3]nicotine binding sites, confirming this compound's novel ni
cotinic pharmacology. Quantitative autoradiography revealed that alpha-CtxM
II binds with high affinity at a subset of [H-3]epibatidine binding sites w
ith relatively low cytisine affinity ("cytisine-resistant" sites), resolvin
g [H-3]epibatidine binding into three different populations, each probably
corresponding to a receptor subtype. The majority population seems to corre
spond to that which binds nicotine and cytisine with high affinity ("cytisi
ne-sensitive" sites). Comparison of the cytisine-resistant population's dis
tribution with that of alpha 3 subunit mRNA expression suggests that the fr
actions both more and less sensitive to alpha-CtxMII probably contain the a
lpha 3 subunit, perhaps in combination with different beta subunits.